WSBTV Narconon GA Part 3 2012-10-03
WSBTV Narconon GA Part 3 2012-10-03 – WSB TV Action News Atlanta, GA investigative report of the tragic death of Patrick Desomond in 2008. Whistleblower, memo link Georgia Narconon to Scientology Channel 2 Investigation looks at nonprofit rehab program after patient death By Jodie Fleischer ATLANTA — A worldwide drug treatment program that’s denied its affiliation with the Church of Scientology faces new scrutiny now that a whistleblower has come forward. Channel 2 Action News has uncovered documents which tie Narconon of Georgia to the controversial church. Channel 2 investigative reporter Jodie Fleischer obtained records that show the director of the Georgia program knew staff members were drinking and doing drugs with patients. A whistleblower told Fleischer the program was more focused on its image than fixing problems and the church uses Narconon to make money and recruit vulnerable addicts into Scientology. Lucas Catton told Flesicher he knows the Narconon drug treatment program better than almost anyone. He went through it as a student, and then rose to be become president of the Flagship Arrowhead facility in Oklahoma. “Is it what it pretends to be? Absolutely not,” said Catton. “Narconon is, essentially it is Scientology.” read more and follow at: www.wsbtv.com
Biotie Interim report 1 January – 30 September 2012
Filed under: drug treatment news 2012
Nepicastat (SYN117): Phase 2 study ongoing, funded by the US Department of Defense, for the treatment of post-traumatic stress disorder (PTSD); top-line data are expected in H2 2012. Under the agreement with the National Institute on Drug Abuse (NIDA) …
Read more on Reuters
The Medical Letter and NewCrop Partner to Provide The Medical Letter's Drug …
Filed under: drug treatment news 2012
1, 2012 — /PRNewswire-USNewswire/ — The Medical Letter announces a new strategic partnership with NewCrop, LLC to incorporate The Medical Letter's objective drug information into NewCrop's leading electronic prescribing platform. … The Medical …
Read more on Sacramento Bee
Gilead's Once-Daily Novel Prodrug for the Treatment of HIV Meets 24-Week …
Filed under: drug treatment news 2012
Gilead submitted a New Drug Application (NDA) to FDA for elvitegravir on June 27, 2012, and the agency has set a target action date under the Prescription Drug User Fee Act (PDUFA) of April 27, 2013. About Cobicistat. Cobicistat is Gilead's proprietary …
Read more on DailyFinance